SMTI
Sanara MedTech Inc. Common Stock
Pre-Market
35.10
Sanara MedTech Inc. Common Stock Profile
About
Info & Links
CEO
Seth D. Yon
Headquarters
Fort Worth, TX 76102, UNITED STATES
Industry
Sector
Website
Auditor
Weaver and Tidwell, L.L.P
Share holders
290
Employees
108
Sanara MedTech Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
322.50M
Enterprise Value
353.56M
Enterprise Value/EBITDA(ttm)
30.41
Price to Earnings Ratio(ttm)
160.36
Price to Sales(ttm)
2.95
Price to Book(mrq)
40.75
Price to Cash(ytd)
59.34
Profitability
Gross Margin(ttm)
93.03%
Operating Margin(ttm)
1.83%
Profit Margin(ttm)
-30.32%
Return on Equity(ttm)
29.72%
Return on Invested Capital(ttm)
-0.51%
Return on Assets(ttm)
2.84%
Income Statement
Revenue(ttm)
109.81M
Revenue Per Share(ttm)
11.95
Gross Profit(ttm)
102.16M
EBITDA(ttm)3
11.63M
Net Income Available to Common(ttm)
-32.02M
Diluted EPS(ttm)
-3.59
Share Statistics
Beta (5Y Monthly)
1.16
52-Week Change
7.77%
S&P 500 52-Week Change
19.38%
S&P 500 Member
No
Stock Optionable
Yes
Total Shares Outstanding1
9.19M
Dividend Yield
0.00%
Float4
5.33M
% Held by Insiders
42.00%
% Held by Institutions
8.10%
Balance Sheet
Total Cash(mrq)
15.42M
Total Cash Per Share(mrq)
1.68
Total Debt(mrq)
46.48M
Total Debt/Equity(mrq)
585.76%
Current Ratio(mrq)
2.58%
Quick Ratio(mrq)
2.30%
Book Value Per Share(mrq)
0.86
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.05
Free Cash Flow(ytd)
-476.00K
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.